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@it-chiba.ac.jp (H. Takaku).The identiﬁcation of cellular proteins that interact with the human immunodeﬁciency virus type 1
(HIV-1) long terminal repeat (LTR) provides a basic understanding of HIV-1 gene expression, which
is the major determinant regulating virus replication. We show that ZBRK1 negatively regulates the
HIV-1 LTR. Ectopic expression of ZBRK1 represses transcriptional activity of the HIV-1 LTR, whereas
the depletion of endogenous ZBRK1 leads to activation of the HIV-1 LTR. The repressor activity of
ZBRK1 is required for TRIM28 binding. Furthermore, ZBRK1 is bound to the HIV-1 LTR in vivo. These
results indicate that ZBRK1 could be involved in a potent intrinsic antiretroviral defense.
Structured summary of protein interactions:
ZBRK1 physically interacts with TRIM28 by anti tag coimmunoprecipitation (View interaction).
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction of the DNA damage-responsive gene GADD45 following cellularThe binding of host factors to long terminal repeats (LTRs) of
proviral DNA tightly regulates retroviral gene expression. Recent
reports have shown that TRIM28 (tripartite motif-containing pro-
tein 28; also known as KRAB-associated protein 1 (KAP1)), a
well-characterized transcriptional repressor, suppresses endoge-
nous retroviruses by recruiting the H3K9 methyltransferases ESET
(also called SETDB1 or KMT1E) and heterochromatin protein 1
(HP1) in mouse ES cells [1–2]. Exogenous retroviruses, such as
moloney murine leukemia virus (M-MLV), are also silenced by
TRIM28 in ES cells [3]. TRIM28-mediated gene-speciﬁc transcrip-
tional repression requires a Krüppel-associated box (KRAB)-zinc
ﬁnger protein, such as ZFP809, to directly recognize integrated vir-
al DNA [4]. Allouch et al. have proposed that TRIM28 inhibits HIV-1
replication by suppressing IN acetylation during integration [5].
KRAB-zinc ﬁnger proteins have the potential to regulate HIV-1
gene expression. Several groups have reported that artiﬁcially engi-
neered KRAB domain-containing zinc ﬁnger proteins that bind to
HIV-1 sequences also induce proviral silencing [6,7]. By contrast,
endogenous OTK18, which contains 13 C2H2-type zinc ﬁnger motifs
and a KRAB domain and was identiﬁed by differential display of
mRNA from HIV type 1-infected macrophages, was shown to inter-
act with and suppress the NRE within the HIV-1 LTR [8]. Thus, some
KRAB-zinc ﬁnger proteins efﬁciently inhibit HIV-1 replication.
ZBRK1, which is also known as KRAB-zinc ﬁnger protein, binds
to the GGGxxxCAGxxxTTT DNA recognition motif within intron 3chemical Societies. Published by E
(H. Nishitsuji), hiroshi.takakuDNA damage. Previously, breast cancer susceptibility gene1
(BRCA1), which has been shown to interact physiologically with
ZBRK1 [9], was identiﬁed through large-scale screening as a host
factor for HIV-1 replication [10].
ZBRK1 has been implicated in the tumorigenesis of several hu-
man cancers. BRCA1, CtIP, and ZBRK1 form a repressor complex at
a ZBRK1 recognition site within the ANG1 promoter, and a defect
in the formation of this repressor complex de-represses ANG1
expression. This complex promotes the survival of neighboring
endothelial cells [11]. Moreover, ZBRK1 and the ATXN2 complex
regulate SCA2 gene transcription and have been linked to cellular
RNA metabolism and endocytotic processes.
We report here the molecular characterization of ZBRK1-
mediated HIV-1 LTR repression. ZBRK1 acts as a transcriptional
repressor of the HIV-1 LTR in a TRIM28-dependent manner. These
data shed further light on the mechanistic role of ZBRK1 in HIV-1
gene expression.
2. Materials and methods
2.1. Plasmids
The details of the plasmid constructs used in this study are pro-
vided in the Supplementary Materials and methods section.
2.2. Preparation of lentiviral vectors
293T cells (1  106) were plated in 60-mm dishes and
co-transfected with the appropriate lentiviral-shRNA expressionlsevier B.V. All rights reserved.
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pMD.G (0.5 lg), the rev expression vector pRSV-Rev (0.5 lg), and
the gag-pol expression vector pMDLg/pRRE (1.2 lg) using Lipofect-
amine 2000 (Invitrogen). At 48 h post-transfection, the culture
supernatants were harvested and ﬁltered through 0.45-lm pore
size ﬁlters.
2.3. CHIP assay
The CHIP assay was performed using the ChIP-IT Express kit
according to the manufacturer’s recommendations (Active Motif,
Carlsbad, California, USA). Brieﬂy, 293T LTR-Luc cells (5  106)
were plated in 100-mm dishes, washed with phosphate-buffered
saline, and treated with 1% formaldehyde for 10 min. After the
reaction was quenched with 0.1 M glycine, the cross-linked mate-
rial was sonicated for ten pulses of 20 s each, with a 30-s rest on ice
between each pulse. Immunoprecipitations were performed with
protein G magnetic beads and 5 lg of either the control antibody
or the anti-ZBRK1 antibody. The chromatin solution was pre-
cleared by adding protein Gmagnetic beads for 2 h at 4 C. The pro-
tein G magnetic beads were blocked with 1 lg/ll of salmon sperm
DNA and 1 lg/ll of bovine serum albumin overnight at 4 C and
then incubated with the chromatin and antibody for 2 h. The
immunoprecipitated material was washed 3 times with the wash
buffer. The cross-linking was reversed by incubating the samples
for 5 h at 65 C in 200 mM NaCl with 10 lg of RNase A to eliminate
any RNA. The recovered material was treated with proteinase K
and extracted using the Wizard SV Gel PCR Clean-Up System (Pro-
mega). The DNA was analyzed by quantitative PCR with StepOne
(Applied Biosystems) and the following primers: 50-TGA CCT TTG
GAT GGT GCT TC-30 and 50-TCC ACA CTA ATA CTT CTC CC-30.
2.4. Immunoprecipitation
293T cells were transfected with 0.5 lg of pNFLAG-ZBRK1 or
pNFLAG-ZBRK1-DV12,13AA using Lipofectamine 2000. At 48 h
post-transfection, the transfected cells were harvested and sus-
pended in 0.5 ml of lysis buffer (20 mM Tris–HCl, pH 7.5;
250 mM NaCl; 1 mM EDTA; 5% glycerol; 1% Triton X-100). The cell
lysates were centrifuged at 15,000g for 20 min at 4 C. The super-
natants were incubated with 1 lg of anti-TRIM28 antibody and
40 ll of protein G-magnetic beads for 2 h at 4 C. The beads were
washed with PBS containing 0.02% Triton X-100. The immunocom-
plex was eluted by boiling with 20 ll of 5 sample buffer and was
analyzed by SDS–PAGE and Western blotting.
2.5. MAGI assay
MAGI cells were plated in 96-well plates at 1  104 cells per
well in Dulbecco’s modiﬁed Eagle’s medium with 10% fetal bovine
serum. The next day, the cells were infected with dilutions of the
virus in a total volume of 50 ll in the presence of 20 lg/ml of
DEAE-dextran for 2 h. At 2 days post-infection, the cells were ﬁxed
with 100 ll of ﬁxative (1% formaldehyde/0.2% glutaraldehyde in
PBS) at room temperature for 5 min and then washed twice with
PBS. The cells were incubated with 100 ll of staining solution
(4 mM potassium ferrocyanide, 4 mM potassium ferricyanide,
2 mM MgCl2, and 0.4 mg/ml X-Gal) for 50 min at 37 C. The reac-
tion was halted by removing the staining solution, and the blue
cells were then counted using a microscope.
2.6. Real-time RT-PCR
Total RNA was extracted from shControl- or shZBRK1-trans-
duced cells using RNeasy Mini kits (Qiagen), and cDNA was
prepared with Revatra Ace (Toyobo) using oligo(dT) primers.Quantitative real-time PCR was performed with the Power SYBR
Green PCR Master Mix (Applied Biosystems), and ﬂuorescent
signals were analyzed with the StepOne RT-PCR system (Applied
Biosystems). The PCR primer pairs used were as follows: ZBRK1-
F, 50-AGA AAC AAG AGG CAG CCA AG-30; ZBRK1-R, 50-GGC TGT
CCC ACA AGG ACT AC-30; beta-actin-F, 50-GTA CCA CTG GCA TCG
TGA TGG ACT-30; and beta-actin-R, 50-CCG CTC ATT GCC AAT GGT
GAT-30.
2.7. Luciferase assay
The details of the luciferase assay are provided in the
Supplementary Materials and methods section.
2.8. Measurement of HIV-1 p24 antigen
The details of the measurement of the p24 antigen are provided
in the Supplementary Materials and methods section.
2.9. Electrophoresis mobility shift assay (EMSA)
The details of the EMSA are provided in the Supplementary
Materials and methods section.
3. Results and discussion
3.1. ZBRK1 suppresses HIV-1 LTR promoter activity
We initially determined whether ZBRK1 could inhibit HIV-1 LTR
promoter activity. To do this, we co-transfected 293T cells with the
ZBRK1 expression vector and the HIV-1 LTR-driven luciferase re-
porter plasmid. Ectopic expression of ZBRK1 reduced the luciferase
activity (Fig. 1A). Additionally, ZBRK1 reduced the LTR-driven lucif-
erase mRNA level (Fig. 1B). To investigate whether ZBRK1 could re-
press full-length HIV-1 transcription, the viral titer of an HIV-1
molecular clone (NL4-3) produced from 293T cells expressing
ZBRK1 was determined in MAGI cells. We observed that expression
of ZBRK1 signiﬁcantly reduced the viral titer (Fig. 1C). Moreover,
we determined whether ZBRK1 could affect p24 antigen expres-
sion, which would result in a loss of viral titer. The expression of
ZBRK1 resulted in a decrease in HIV-1 p24 antigen production in
intracellular and culture supernatants (Fig. 1D). These results sug-
gest that ZBRK1 represses not only the HIV-1 LTR-driven luciferase
reporter plasmid but also full-length HIV-1 transcription. Next, to
evaluate the function of ZBRK1 in chromatin-mediated repression
of the HIV-1 LTR, we ectopically expressed ZBRK1 in HeLa cells
containing an integrated LTR-luciferase reporter gene (HeLa–
LTR–Luc). We then expressed HIV-1 Tat in HeLa–LTR–Luc cells, as
these cells have a low basal level of luciferase activity. Expression
of ZBRK1 in HeLa–LTR–Luc cells reduced the level of luciferase
activity (Fig. 1E, left). To ensure that the effect observed was not
due to ZBRK1-mediated suppression of Tat gene transcription, we
analyzed Tat expression by Western blotting and found that ZBRK1
had no effect on the Tat expression level (Fig. 1E, right). This result
demonstrates that ZBRK1 plays a signiﬁcant role in chromatin-
mediated repression of the HIV-1 LTR. To investigate the function
of endogenous ZBRK1 in transcriptional repression of the LTR, we
utilized a lentiviral vector encoding an shRNA corresponding to
the ZBRK1 sequence. The expression level of endogenous ZBRK1
was reduced upon introduction of the shZBRK1-expressing lentiv-
iral vector in 293T cells, as measured by qRT-PCR (Fig. 1F). The
knockdown of ZBRK1 expression enhanced the transcriptional
activity of the LTR (Fig. 1G). To further conﬁrm the effect of endog-
enous ZBRK1 in HIV-1-integrated cells, 293T cells were infected
with an HIVNL43-luc pseudotyped virus and then transduced with
the shControl or shZBRK1 vectors. ZBRK1 knockdown signiﬁcantly
Fig. 1. ZBRK1 inhibits HIV-1 LTR-driven transcription. (A) 293T cells were transfected with 1 ng of pLTR-Luc, 1 ng of pCMV-Renilla-Luc and 200 ng of pNFLAG or pNFLAG-
ZBRK1. At 48 h post-transfection, the levels of luciferase gene expression were determined by measuring the luciferase activity. Fireﬂy luciferase activity was normalized to
Renilla luciferase activity. (B) 293T cells were transfected with 200 ng of pNFLAG or pNFLAG-ZBRK1 along with 5 ng of pLTR-Luc. At 48 h post-transfection, the levels of
luciferase mRNAwere determined by qRT-PCR. Quantiﬁcation of the beta-actin gene was performed as an internal control to correct for sample-to-sample variations in mRNA
levels. (C, D) 293T cells were transfected with 200 ng of pNL4–3 and 300 ng of pNFLAG or pNFLAG-ZBRK1. At 48 h post-transfection, the virus titer (as shown, TCID50/ml (C))
were measured by MAGI assay. The amounts of p24 antigen in the intracellular compartments (D, left panel) and culture supernatants (D, right panel) were measured by a
chemiluminescent enzyme immunoassay (CLEIA). (E) HeLa-LTR-Luc cells were transfected with 500 ng of pCMV-Tat-V5 and 500 ng of pNFLAG or pNFLAG-ZBRK1. At 48 h
post-transfection, the cell lysates were analyzed for luciferase activity (left panel), and Tat-V5, FLAG-ZBRK1 and tubulin expression by Western blotting (right panel). (F, G)
293T cells were infected with the indicated lentiviral vectors. At 48 h post-infection, the cells were transfected with 5 ng of pLTR-Luc. At 48 h post-transfection, the levels of
ZBRK1 mRNA (F) and luciferase activity (G) were determined by quantitative RT-PCR and a luciferase assay, respectively. Quantiﬁcation of the beta-actin gene was performed
as an internal control to correct for sample-to-sample variations in mRNA levels. (H) The pseudotyped virus was generated by co-transfection of 293T cells with 1 lg of the
pNLlucDenv and 1 lg of pMD.G. The culture supernatants were harvested at 48 h post-transfection and ﬁltered through 0.45-lm pore size ﬁlters. 293T cells were infected
with VSV-G pseudotyped NL-Luc [12]. At 1 h post-infection, 293T cells were infected with the lentiviral vectors expressing shControl or shZBRK1. At 48 h post-shRNA
transduction, the levels of luciferase gene expression were determined by measuring luciferase activity. (I) MT-4 cells were infected with the lentiviral vectors expressing
shControl or shZBRK1. At 5 days post-infection, the cells were infected with 2 ng of NL4-3 p24. Virus replication was monitored every 3 days after infection by measuring p24
viral antigen in the culture supernatant. The results are representative of three independent experiments, and error bars show the standard deviation of the mean values.
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(Fig. 1H). To evaluate the effect of ZBRK1 in T cells, MT-4 cells were
transduced with the control or ZBRK1-speciﬁc shRNA vectors and
then infected with HIV-1. Virus replication was monitored by mea-
suring the production of p24 in the supernatant every 3 days post-
infection. The depletion of ZBRK1 in MT-4 cells conferred a 2-fold
enhancement on HIV-1 replication at 6 and 9 days post-infection
(Fig. 1I). These results suggest that ZBRK1 inhibits HIV-1 gene
expression through transcriptional repression of the LTR.
3.2. Identiﬁcation of potential ZBRK1 response elements in the HIV-1
LTR
To determine the LTR sequence responsible for the suppressive
function of ZBRK1, we generated deletion mutants of the LTR
(Fig. 2A). The expression of ZBRK1 repressed transcription from
the 335 to +282 LTR segment (Fig. 2C), the 245 to +282 LTR seg-
ment (Fig. 2D), and the full-length LTR (Fig. 2B). By contrast, repres-
sion of the LTR by ZBRK1 was abolished by the deletion of LTR
sequences corresponding to 454 to 107 (Fig. 2E). These results
suggest that the 454 to 107 region within the LTR containsFig. 2. The region of ZBRK1 responsible for transcriptional repression of the HIV-1 LTR. (A
numbers are relative to the transcription start site nucleotide +1. (B–G) 293T cells were t
along with 5 ng of pLTR-Luc (B) or its corresponding mutants (C–G). The luciferase assay
pCMV-Renilla-Luc, 5 ng of pLTR-Luc and 100 ng of pCMV-Tat along with 200 ng of pNFLA
results are representative of three independent experiments, and error bars show the stessential elements for transcriptional repression by ZBRK1. To
further deﬁne the ZBRK1-responsive region of the LTR, we con-
structed several more precise deletion mutants of the LTR
(Fig. S1A). Similar to the wild type LTR, transcription from the LTR
deletion corresponding to 205 to 146 was decreased by expres-
sion of ZBRK1 (Fig. S1B). However, deletion of the LTR corresponding
to145 to126 partially impaired the suppressive effect of ZBRK1.
These results indicate that the 145 to 126 rejoin of the LTR is a
candidate for transcriptional repression by the ZBRK1.
A previous study has shown that transcriptional silencing of the
HIV-1 LTR by HP1-gamma requires Sp-1, P-TEFb (which leads to
the phosphorylation of RNA polymerase IICTD by recruiting HIV-
1 Tat to the TAR) and PCAF (which is known to possess histone
acetyl transferase activity) [13].
To further determine the role of cis-elements of the LTR in ZBRK1
repression,we introducedmutations into theNF-jB or Sp-1 binding
sites of the LTR. However, mutations of the NF-jB and Sp-1 binding
sites within the LTR did not affect ZBRK1 repression (Fig. 2F and G).
In addition, HIV-1 Tat was also not required for the repressive activ-
ity of ZBRK1 (Fig. 2H). These results suggest that ZBRK1 directly re-
presses transcriptional activity of the HIV-1 LTR.) A schematic representation of HIV-1 LTR-driven expression of ﬁreﬂy luciferase. The
ransfected with 1 ng of pCMV-Renilla-Luc and 200 ng of pNFLAG or pNFLAG-ZBRK1
was performed as described in Fig. 1A. (H) 293T cells were transfected with 1 ng of
G or pNFLAG-ZBRK1. The luciferase assay was performed as described in Fig. 1A. The
andard deviation of the mean values.
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TRIM28
KRAB-zinc ﬁnger proteins interact with TRIM28 through their
KRAB box [14]. This interaction represses the target gene by
recruiting the histone methyltransferases SETDB1 and HP1 [15].
To investigate the mechanism involved in ZBRK1-mediated repres-
sion of the LTR, we used siRNAs speciﬁc for TRIM28, HP1-gamma
or SETDB1 in either empty plasmid-transfected or ZBRK1 expres-
sion plasmid-transfected cells. The introduction of each speciﬁc
siRNA induced the efﬁcient knockdown of that particular protein
(Fig. 3A). The expression of ZBRK1 in siControl-transduced cells
conferred a 2.4-fold repression of LTR-driven transcription
(Fig. 3B). The depletion of HP1-gamma or SETDB1 had no signiﬁ-Fig. 3. TRIM28 is required for the repressive activity of ZBRK1. (A) HeLa cells were treated
Luc, 1 ng of pCMV-Renilla-Luc and 300 ng of pNFLAG or pNFLAG-ZBRK1. At 48 h post
indicated protein. (B–E) The protein lysates in Fig. 3A were analyzed for luciferase activit
within the graph represent the fold change of luciferase activity. (F) 293T cells were tra
pNFLAG, pNFLAG-ZBRK1 or pNFLAG-ZBRK1-DV12,13AA. The luciferase assay was perform
ZBRK1 or pNFLAG-ZBRK1-DV12,13AA. At 48 h post-transfection, the cell lysates were
analysis with an anti-TRIM28 antibody. The results are representative of three independcant effect on the ZBRK1-mediated repression of LTR transcription
(Fig. 3C and D, 2.5-fold and 2.7-fold, respectively). By contrast, no
repressive activity of ZBRK1 was observed in the siTRIM28-trans-
duced cells (Fig. 3E). To further verify the TRIM28 requirement
for the repressive activity of ZBRK1, we introduced two substitu-
tion mutations (DV to AA) within the KRAB domain that have
previously been shown to disrupt the repressive function of KRAB
domain-containing proteins. Relative to wild-type ZBRK1,
ZBRK1-DV12,13AA was signiﬁcantly defective in repression of
LTR activity (Fig. 3F). Furthermore, FLAG-ZBRK1 was found to
interact with endogenous TRIM28, but this interaction was less
efﬁcient with FLAG-ZBRK1-DV12,13AA (Fig. 3G). These results
indicate that TRIM28 plays an essential role in the repressive
function of ZBRK1.with 70 nM of the indicated siRNA for 24 h, prior to transfection with 5 ng of pLTR-
-transfection, the protein lysates were run on SDS–PAGE gels and probed for the
y. Fireﬂy luciferase activity was normalized to Renilla luciferase activity. The values
nsfected with 1 ng of pCMV-Renilla-Luc and 5 ng of pLTR-Luc along with 200 ng of
ed as described in Fig. 1A. (G) 293T cells were transfected with 500 ng of pNFLAG-
immunoprecipitated using an anti-FLAG antibody, followed by Western blotting
ent experiments, and error bars show the standard deviation of the mean values.
Fig. 4. ZBRK1 binds to the HIV-1 LTR in vivo. (A) An EMSA was performed by using a biotin-labeled probe corresponding to the LTR sequence (174 to 95) and nuclear
extracts from 293T cells transfected with empty plasmid or pNFLAG-ZBRK1 in the presence of control antibody or anti-ZBRK1 antibody. (B) Chromatin immunoprecipitations
using anti-ZBRK1 and control Ig. PCR was performed using primers speciﬁc to the U3 region of the HIV-1 LTR. The PCR products were separated on 1.5% agarose gels and
stained with SYBER Green. (C) Immunoprecipitated DNA was subjected to real-time PCR using primers speciﬁc to the U3 region of the HIV-1 LTR, as described in the materials
and methods. The amount of immunoprecipitated DNA was normalized to the input DNA. The data are representative of three independent experiments. (D) The level of
TRIM28 at the LTR in ZBRK1 knockdown cells.
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As previously described, TRIM28 interacts with Mi-2alpha and
other components of the NuRD complex. Additionally, TRIM28-
mediated silencing requires associationwithNuRD andHDAC activ-
ity. By contrast, trimethylation of histone H3 on lysine 9 by SETDB1
creates high-afﬁnity genomic binding sites for the TRIM28–HP1
complex, suggesting that SETDB1 may play an important role in
TRIM28-mediated repression. However, our data indicated that
SETDB1 and HP1-gamma did not affect ZBRK1-induced repression
of LTR transcription (Fig. 3C and D).
To test whether histone deacetylases play a role in the repres-
sion of LTR activity by ZBRK1 in HeLa–LTR–Luc cells, we used the
pan-HDAC inhibitor trichostatin A (TSA). Treatment with 400 nM
of TSA signiﬁcantly reversed ZBRK1-mediated repression in
HeLa–LTR–Luc cells (Fig. S2A). Moreover, the repressive activity
of ZBRK1 decreased in HDAC2-depleted cells (Fig. S2B). These
results indicate that ZBRK1-mediated suppression of LTR activity
requires HDAC2 activity.
3.5. ZBRK1 is enriched at the HIV-1 LTR
To investigate whether ZBRK1 could bind to the LTR, we per-
formed a gel mobility shift assay using nuclear extracts from 293T
cells ectopically expressing FLAG-ZBRK1. A shift of the LTR probe
corresponding to LTR sequence (175 to 95) was observed after
incubationwith nuclear extracts prepared from 293T cells transfec-
ted with empty plasmid or pNFLAG-ZBRK1 (Fig. 4A). However, a
supershift of the labeled probe could not detect in the presence ofanti-ZBRK1 antibody. This can be attributed to low levels of ZBRK1
expression in 293T cells (data not shown). In contrast, coincubation
of the nuclear extracts from 293T cells expressing FLAG-ZBRK1with
anti-ZBRK1 antibody but not control antibody caused a supershift of
the labeled probe. These results indicated that ZBRK1 can form a
complex with HIV-1 LTR. If ZBRK1 is indeed critical for transcrip-
tional repression of the HIV-1 LTR, it should be bound to the HIV-1
LTR in vivo. To test whether the HIV-1 LTR is bound by endogenous
ZBRK1, LTR-integrated cells were analyzed by chromatin immuno-
precipitation assay (CHIP assay) using an anti-ZBRK1 antibody.
ZBRK1 enrichment was detected in the LTR (Fig. 4B). The level of
CHIPenrichmentwasdeterminedbyCHIP-qPCR (Fig. 4C). Inparallel,
the level of binding to the housekeeping GAPDH gene was not de-
tected by ZBRK1 enrichment (data not shown). To investigate
whether ZBRK1 is required for recruitment of TRIM28 to the LTR,
ZBRK1-depleted cells were analyzed by the CHIP assay using an
anti-TRIM28 antibody. TRIM28 can bind to the LTR (Fig. 4D). More-
over, the depletion of ZBRK1 results in a 25% reduction in the level of
TRIM28 at the LTR. These results indicate that ZBRK1 can bind to the
HIV-1 LTR and partially inﬂuence recruitment of TRIM28 to the LTR.
In conclusion, our data demonstrate that ZBRK1, in conjunctionwith
TRIM28 and HDAC2, suppresses HIV-1 LTR-driven gene expression.
The results of this study suggest that stimulationof KRAB-zincﬁnger
proteins may aid in the development of antiviral therapies.
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